QQ客服 官方微博 反馈留言

	Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study
	An, Ning; Wang, Haoyi; Li, Ji; Zhai, Xiaoyang; Jing, Wang; Jia, Wenxiao; Kong, Li; Zhu, Hui; Yu, Jinming
刊名	ONCOTARGETS AND THERAPY
	2019
卷号	12页码:8311-8318
关键词	non-small cell lung cancer EGFR mutation brain metastasis radiotherapy tyrosine kinase inhibitor
DOI	10.2147/OTT.S223216
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4553518
专题	山东大学
作者单位	1.Shandong Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China. 2.Shandong Univ, Qilu Hosp, D
推荐引用方式 GB/T 7714	An, Ning,Wang, Haoyi,Li, Ji,et al. Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study[J]. ONCOTARGETS AND THERAPY,2019,12:8311-8318.
APA	An, Ning.,Wang, Haoyi.,Li, Ji.,Zhai, Xiaoyang.,Jing, Wang.,...&Yu, Jinming.(2019).Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study.ONCOTARGETS AND THERAPY,12,8311-8318.
MLA	An, Ning,et al."Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study".ONCOTARGETS AND THERAPY 12(2019):8311-8318.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。